# PK and PD Study of NPI-001 and Cysteamine Bitartrate

> **NCT05994534** · PHASE1,PHASE2 · RECRUITING · sponsor: **Nacuity Pharmaceuticals, Inc.** · enrollment: 12 (estimated)

## Conditions studied

- Cystinosis

## Interventions

- **DRUG:** Cysteamine Bitartrate
- **DRUG:** N-Acetylcysteine Amide

## Key facts

- **NCT ID:** NCT05994534
- **Lead sponsor:** Nacuity Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-29
- **Primary completion:** 2026-06
- **Final completion:** 2026-08
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05994534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05994534, "PK and PD Study of NPI-001 and Cysteamine Bitartrate". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05994534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*